TSH announces TFDA acceptance TSH announces TFDA acceptance Tyrvaya® for Dry Eye Nasal Spray, expected approval by late 2024.
2024.1.3
...
.jpg)
TSH Biopharm was invited to attend the institutional investor conference hosted by KGI Securities
2023.12.21
...
.jpg)
To announce the change of financial officer and acting spokesperson of the Company
2023.12.14
...
.jpg)
.jpg)
Announcement of the BOD's approval regarding the participation in cash injection of Chuang Yi Biotech Co., Ltd.
2023.11.2
...
.jpg)
TSH Board of Directors Approved Financial Statements For the Nine Months Ended September 30, 2023
2023.11.2
...
